Trial intelligence / Profile preview

Comparison of Zeldox and Abilify on cognition and sleep in schizophrenia

2005-004501-28Phase 4Completed

Sponsor
Department of Psychiatry, LMU Munich
Start
Jun 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in schizophrenia comparing Zeldox arm with Abilify arm (2 arms). Primary endpoint: Cognitive functioning and sleep quality. Started Jun 2007; status: completed.

02

Drugs

ziprasidonearipiprazole
03

Conditions

schizophrenia

Beyond the preview

Go deeper on 2005-004501-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-004501-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call